Expecting probable public ridicule, I'm presenting my new

New Post Public Reply Private Reply Replies (3) Message Board
ace thompson
508
Expecting probable public ridicule, I'm presenting my new Unified Theory of SFT.

There are 3 issues about the company that I've been thinking about, too much, probably:

1) how will share price ever substantially increase when the re-sellers are rebranding the software and the SFT name won't get out there? I know about the guys who scan the penny sheets, whatever, that would be inches, when we want yards.

2) how will the 3 new patents, if granted, impact current deals? Are they for improvements on current software or for new products?

3) How can Mr Kay simultaneously maintain that we'll be in the black by August, but he can't determine when revenue from current deals will hit the books. This isn't arguing for the sake of arguing, I think reconciling these two ideas might be the crux of the issue.

The only thing I can think of to explain all of the above, is that the company is currently in the process of being sold and should wrap up sometime this summer. The price has been agreed upon, which is how Mr Kay knows about being in the black and share price is irrelevant to the buyer as long as they can see deals and revenues on the books.

If the new patents are for new software, that leaves open the door for a new company with them, BlockSafe, and possibly, Crypto, and us divvying up the proceeds of the sale and, maybe, receiving shares in the new company.

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading